Kamalesh, Babu,Ruppa, Poornachary,Myers, Scott James
申请号：
AU2013203908
公开号：
AU2013203908A1
申请日:
2013.04.11
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
#$%^&*AU2013203908A120130502.pdf#####ABSTRACT Provided are compounds, pharmaceutical compositions and methods of treatment or prophylaxis of certain neurologic disorders, including disorders related to NMDA receptor activation, including neuropsychiatric disorders, neurodegenerative disorders and other neurologic diseases, disorders and conditions including stroke, brain injury, epilepsy, neuropsychiatric disorders, mood disorders, chronic pain and related conditions. The compounds are of the general Formula I [structure], or a pharmaceutically acceptable salt, ester, prodrug or derivative thereof are provided: wherein Arl, Ar2 m, n, p and q A R3 Q Y R X and Z are defined herein.
